JENNISON ASSOCIATES LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$21,554,000
+41.3%
186,760
+19.2%
0.02%
+25.0%
Q3 2020$15,252,000
-50.9%
156,670
-41.9%
0.01%
-63.6%
Q3 2019$31,043,000
-59.0%
269,865
-38.5%
0.03%
-56.0%
Q2 2019$75,671,000
+17.6%
438,955
+15.0%
0.08%
+17.2%
Q1 2019$64,351,000
+28.2%
381,745
-25.9%
0.06%
+14.3%
Q4 2018$50,183,000
-21.5%
515,281
+39.2%
0.06%
-5.1%
Q3 2018$63,923,000
-3.7%
370,054
-22.2%
0.06%
-9.2%
Q2 2018$66,398,000
+9.5%
475,833
-11.6%
0.06%
+8.3%
Q1 2018$60,649,000
-6.2%
538,293
+9.9%
0.06%
-6.2%
Q4 2017$64,670,000
+29.4%
489,890
-0.5%
0.06%
+25.5%
Q3 2017$49,982,000
+1.6%
492,480
+0.4%
0.05%
-1.9%
Q2 2017$49,195,000
-12.8%
490,721
+5.2%
0.05%
-14.8%
Q1 2017$56,400,000
+237.8%
466,345
+212.1%
0.06%
+221.1%
Q4 2016$16,698,000
-15.5%
149,419
+0.3%
0.02%
-9.5%
Q3 2016$19,771,000
+177.3%
148,958
+91.3%
0.02%
+162.5%
Q2 2016$7,131,000
-59.4%
77,871
-59.5%
0.01%
-55.6%
Q3 2015$17,574,000
-36.1%
192,343
-14.1%
0.02%
-28.0%
Q2 2015$27,492,000
-0.8%
223,805
-26.4%
0.02%0.0%
Q1 2015$27,721,000
+58.2%
304,196
+17.5%
0.02%
+56.2%
Q4 2014$17,523,000
-18.1%
258,914
+29.9%
0.02%
-20.0%
Q2 2014$21,385,000
+89.0%
199,316
+4.6%
0.02%
+81.8%
Q1 2014$11,314,000190,5730.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders